In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-c20 epoxide metabolite

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1074-1081

  Lhoest G ^a,c   Dieden, R ^a   Verbeeck, R K ^a   Maton, N ^c   Ingendoh, A ^c   Latinne, D ^b  

^a Laboratory of Mass Spectrometry   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Dept of Pharmaceutical Sciences ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN A [8 DEXTRO O (2 HYDROXYETHYL)SERINE]; EPOXIDE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LIVER MICROSOME; MASS SPECTROMETRY; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SWINE;

ANIMALS; EPOXY COMPOUNDS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; MASS SPECTROMETRY; MICROSOMES, LIVER; SWINE; TACROLIMUS;

EID: 0031888807     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Amar-Costesec A, Beaufay A, Wibo M, Thines-Sempoux D, Feytimans E, Robbi M and Berthet J (1974) Analytical study of microsomes and isolated subcellular membranes from rat liver. J Cell Biol 61:201-212.
2. Braun W, Kallen J, Mikol V, Walkinshaw MD and Wütherich K (1995) Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J 9:63-72.
3. Christians U, Braun F, Kosian N, Schmidt M, Schiebel M, Ernst L, Kruse C, Winkler M, Holze I, Linck A and Sewing KFr (1991) High performance liquid chromatography/mass spectrometry of FK-506 and its metabolites in blood, bile and urine of liver-grafted patients. Transplant Proc 23:2741-2744.
4. Friedman J and Weissman I (1991) Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA. Cell 66:799-806.
5. Harding WM, Galat A, Uehling DE and Speicher DW (1989) A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl-prolyl-isomerase. Nature (Lond) 341:758-760.
6. Hane K, Fujioka M, Namiki Y, Kitagawa T, Kihara N, Shimatani K and Yasuda T (1992) Physico-chemical properties of (-)-(1 R, 9 S, 12 S, 13 R, 14 S, 17 R, 18 E, 21 S, 23 S, 24 R, 25 S, 27 R)-17-allyl-1, 14-dihydroxy-12-[(E)-2-[(1 R, 3 R, 4 R)-4-hydroxy-3-methoxycyclohexyl]-l-methylvinyl]-23, 25-dimethoxy-13, 19, 21, 27-tetramethyl-11, 28-dioxa-4-azatricyclo[22,3.1.0] octacos-18-ene-2, 3, 10, 16-tetrone hydrate (FK-506). Iyakuhin Kenkyu 23:33-44.
7. Iwasaki K, Shiraga T, Matsuda H, Nagase K, Tokuda Y, Hata T, Fugii Y, Sakuma S, Fujitsu T, Fujikawa A, Shimatani K, Sato A and Fujioka M (1995) Further metabolism of FK506 (Tacrolimus): Identification and biological activities of the metabolites oxidized at multiple sites of FK-506. Drug Metab Disp 23:28-34.
8. Iwasaki K, Shiraga T, Nagase K, Tozuka Z, Noda S, Sakuma S, Fujitsu T, Shimatani K, Sato A and Fujioka M (1993) Isolation, identification and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone. Drug Metab Disp 21:971-977.
9. Kuo CJ, Chung J, Florentino DF, Flanagan WM, Blenis J and Crabtree GR ( 1992) Rapamycin selectively inhibits interleukin-2 activation of 170 S6 kinase. Naturt (Lond) 358:70-73.
10. Lane WS, Galat A, Harding MW and Schreiber SL (1991) Complete amino acid sequence of the FK-506 and rapamycin binding protein, FKBP, isolated from calf thymus. J Protein Chem 10:151-160.
11. 37 dihydrodiol from erythromycin-induced rabbit liver microsomes. J Pharmaceut Biomed Anal 12:235-241.
12. 15-demethylated metabolite of FK-506 is governed by ring-and open-chain tautomerism effects. J Pharm Exp Ther 274: 622-626.
13. Liu, J Farmer JD, Lane WS, Friedman J, Weismann I and Schreiber SL (1991) Calcineurin is a common target of cyclosporin-cyclosporin A and FFKBP-FK506 complexes. Cell 66:807-815.
14. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
15. Morris R (1994) Modes of action of FK-506, cyclosporin A, and rapamycin. Transplant Proc 26:3272-3275.
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55-63.
17. Nike M and Otto M (1990) Towards an optimized MTT assay. J Immunol Meth 130:149-151.
18. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
19. Sattler M, Guengerich FP, Yun CH, Christians U and Sewing KF (1992) Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab and Disp 20:753-761.
20. Shieh BH, Stamnes MA, Seavelb S, Harris GL and Zuker CS (1989) The nina A gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature (Land) 338:67-70.
21. Siekirka JJ, Hung SHY, Poe M, Lin CS and Sigal NH (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341:755-757.
22. Standaert RF, Galat A, Verdine GL and Schreiber SL (1990) Molecular cloning and overexpression of the human FK-506-binding protein, FKBP. Nature (Lond) 346:671-674.
23. Zarling JM, Mc Keough M and Bach FH (1976) A sensitive micromethod for generating and assaying allogenically induced cytotoxic human lymphocytes. Trans-plantation 21:468-476.